A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
Clinical trial NCT01552629 · COMPLETED
Trial details
- NCT number
- NCT01552629
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-05
- Primary completion
- 2013-08-28
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.